Antibiotic prophylaxis and clinical outcomes among older adults with recurrent urinary tract infection: cohort study

<strong>Background</strong> Clinical guidelines recommend antibiotic prophylaxis for preventing recurrent urinary tract infections (UTIs), but there is little evidence for their effectiveness in older adults. <strong>Methods</strong> This was a retrospective coh...

Full description

Bibliographic Details
Main Authors: Ahmed, H, Farewell, D, Jones, H, Francis, N, Paranjothy, S, Butler, C
Format: Journal article
Published: Oxford University Press 2018
_version_ 1797077132913934336
author Ahmed, H
Farewell, D
Jones, H
Francis, N
Paranjothy, S
Butler, C
author_facet Ahmed, H
Farewell, D
Jones, H
Francis, N
Paranjothy, S
Butler, C
author_sort Ahmed, H
collection OXFORD
description <strong>Background</strong> Clinical guidelines recommend antibiotic prophylaxis for preventing recurrent urinary tract infections (UTIs), but there is little evidence for their effectiveness in older adults. <strong>Methods</strong> This was a retrospective cohort study of health records from 19,696 adults aged ≥65 with recurrent UTIs. We used prescription records to ascertain ≥3 months’ prophylaxis with trimethoprim, cefalexin or nitrofurantoin. We used random effects Cox recurrent event models to estimate hazard ratios (HR) and 95% confidence intervals (CI) for risks of clinical recurrence (primary outcome), acute antibiotic prescribing, and hospitalisation. <strong>Results</strong> Of 4043 men and 15,653 women aged ≥65 with recurrent UTIs, 508 men (12.6%) and 2229 women (14.2%) were prescribed antibiotic prophylaxis. In men, prophylaxis was associated with a reduced risk of clinical recurrence (HR, 0.49; 95% CI, 0.45-0.54), acute antibiotic prescribing (HR, 0.54; 95% CI, 0.51-0.57) and UTI-related hospitalisation (HR, 0.78; 95% CI, 0.64–0.94). In women, prophylaxis was also associated with a reduced risk of clinical recurrence (HR, 0.57; 95% CI, 0.55-0.59) and acute antibiotic prescribing (HR, 0.61; 95% CI, 0.59-0.62), but estimates of the risk of UTI-related hospitalisation were inconsistent between our main analysis (HR, 1.16; 95% CI, 1.05-1.28) and sensitivity analysis (HR, 0.82; 95% CI, 0.72-0.94). <strong>Conclusions</strong> Antibiotic prophylaxis was associated with lower rates of UTI recurrence and acute antibiotic prescribing in older adults. To fully understand the benefits and harms of prophylaxis, further research should determine the frequency of antibiotic-related adverse events and the impact on antimicrobial resistance and quality of life.
first_indexed 2024-03-07T00:13:29Z
format Journal article
id oxford-uuid:7a0d3074-16e8-4480-98ba-c616130cb1ad
institution University of Oxford
last_indexed 2024-03-07T00:13:29Z
publishDate 2018
publisher Oxford University Press
record_format dspace
spelling oxford-uuid:7a0d3074-16e8-4480-98ba-c616130cb1ad2022-03-26T20:41:12ZAntibiotic prophylaxis and clinical outcomes among older adults with recurrent urinary tract infection: cohort studyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:7a0d3074-16e8-4480-98ba-c616130cb1adSymplectic Elements at OxfordOxford University Press2018Ahmed, HFarewell, DJones, HFrancis, NParanjothy, SButler, C<strong>Background</strong> Clinical guidelines recommend antibiotic prophylaxis for preventing recurrent urinary tract infections (UTIs), but there is little evidence for their effectiveness in older adults. <strong>Methods</strong> This was a retrospective cohort study of health records from 19,696 adults aged ≥65 with recurrent UTIs. We used prescription records to ascertain ≥3 months’ prophylaxis with trimethoprim, cefalexin or nitrofurantoin. We used random effects Cox recurrent event models to estimate hazard ratios (HR) and 95% confidence intervals (CI) for risks of clinical recurrence (primary outcome), acute antibiotic prescribing, and hospitalisation. <strong>Results</strong> Of 4043 men and 15,653 women aged ≥65 with recurrent UTIs, 508 men (12.6%) and 2229 women (14.2%) were prescribed antibiotic prophylaxis. In men, prophylaxis was associated with a reduced risk of clinical recurrence (HR, 0.49; 95% CI, 0.45-0.54), acute antibiotic prescribing (HR, 0.54; 95% CI, 0.51-0.57) and UTI-related hospitalisation (HR, 0.78; 95% CI, 0.64–0.94). In women, prophylaxis was also associated with a reduced risk of clinical recurrence (HR, 0.57; 95% CI, 0.55-0.59) and acute antibiotic prescribing (HR, 0.61; 95% CI, 0.59-0.62), but estimates of the risk of UTI-related hospitalisation were inconsistent between our main analysis (HR, 1.16; 95% CI, 1.05-1.28) and sensitivity analysis (HR, 0.82; 95% CI, 0.72-0.94). <strong>Conclusions</strong> Antibiotic prophylaxis was associated with lower rates of UTI recurrence and acute antibiotic prescribing in older adults. To fully understand the benefits and harms of prophylaxis, further research should determine the frequency of antibiotic-related adverse events and the impact on antimicrobial resistance and quality of life.
spellingShingle Ahmed, H
Farewell, D
Jones, H
Francis, N
Paranjothy, S
Butler, C
Antibiotic prophylaxis and clinical outcomes among older adults with recurrent urinary tract infection: cohort study
title Antibiotic prophylaxis and clinical outcomes among older adults with recurrent urinary tract infection: cohort study
title_full Antibiotic prophylaxis and clinical outcomes among older adults with recurrent urinary tract infection: cohort study
title_fullStr Antibiotic prophylaxis and clinical outcomes among older adults with recurrent urinary tract infection: cohort study
title_full_unstemmed Antibiotic prophylaxis and clinical outcomes among older adults with recurrent urinary tract infection: cohort study
title_short Antibiotic prophylaxis and clinical outcomes among older adults with recurrent urinary tract infection: cohort study
title_sort antibiotic prophylaxis and clinical outcomes among older adults with recurrent urinary tract infection cohort study
work_keys_str_mv AT ahmedh antibioticprophylaxisandclinicaloutcomesamongolderadultswithrecurrenturinarytractinfectioncohortstudy
AT farewelld antibioticprophylaxisandclinicaloutcomesamongolderadultswithrecurrenturinarytractinfectioncohortstudy
AT jonesh antibioticprophylaxisandclinicaloutcomesamongolderadultswithrecurrenturinarytractinfectioncohortstudy
AT francisn antibioticprophylaxisandclinicaloutcomesamongolderadultswithrecurrenturinarytractinfectioncohortstudy
AT paranjothys antibioticprophylaxisandclinicaloutcomesamongolderadultswithrecurrenturinarytractinfectioncohortstudy
AT butlerc antibioticprophylaxisandclinicaloutcomesamongolderadultswithrecurrenturinarytractinfectioncohortstudy